Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
YAKULT HONSHA surges to new year-to-date high as U.S. investor Dalton publishes shareholder proposal materials
YAKULT HONSHA CO.,LTD. <2267> continued its sharp rise, reaching a new year-to-date high. U.S. investment fund Dalton Investments announced on the 23rd that it had sent documents exercising its shareholder proposal rights at YAKULT HONSHA's annual general meeting scheduled for June, and published explanatory materials. Dalton pointed out that despite YAKULT HONSHA possessing a strong business foundation including its brand and sales channels, the company has not fully realized its potential due to insufficient governance and capital discipline. Dalton is proposing the appointment of two directors from its side, among other measures. In the stock market, expectations have spread that pressure from the activist investor will improve YAKULT HONSHA's capital efficiency and shareholder value, attracting buy orders.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
Sumitomo Bakelite Company Limited rebounds for first time in three days on plans to expand steering microcatheter production capacity
DAIICHI SANKYO shares fall to 4-year low on earnings announcement delay
Shanghai Composite Index opens at 4,081.0326 on the 24th, down 12.2175 points
Crude oil ETFs including NEXT FUNDS NOMURA Crude Oil Long rise as WTI hovers near $97 amid negotiation concerns
STELLA PHARMA CORPORATION rebounds for first time in four days on speculation after Heights Capital disclosed 5.68% stake
Hong Kong's Hang Seng Index opens at 25,733.61 on the 24th, down 181.59 points
Umenoyado Brewery debuts at 900 yen, 50% above IPO price
Oncolys BioPharma Inc. <4588> rises as OBP-301 receives FDA fast track designation in U.S.
Globalway ranks first in rising buy predictions among individual investors on Minkabu
Sockets Inc. <3634> hits daily limit high on upbeat final profit for previous fiscal year